Mednet Logo

How do you approach SRS for brain metastases in the setting of a connective tissue disorder such as lupus or scleroderma?

Do you make any modifications to your dose or treatment technique?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Columbia University Irving Medical Center
Answered on · Updated on

Historically, connective tissue disorders (CTD) have been considered to be a relative contraindication to radiotherapy generally - due to concerns of potential increased risk of complications. Data on this issue is somewhat conflicting. In the setting of SRS for brain metastases or brain tumors, the...

Join for free or sign in to see the full answer